Molluscum contagiosum infection associated with pimecrolimus use in pityriasis alba.

Atopic dermatitis is an inflammatory, chronically relapsing, highly pruritic skin disorder that has considerable impact on the quality of life. As corticosteroids are not ideal for long-term control of the disease because of their potential side effects, steroid-free topical immunomodulators have recently been developed for the treatment of atopic dermatitis. Although clinical trials do not indicate an increased risk of cutaneous infection, the clinician must be careful about viral infections such as eczema herpeticum or molluscum eczema that can be observed during treatment with pimecrolimus and tacrolimus. We report molluscum contagiosum that developed on the preauricular area treated with topical pimecrolimus.
AuthorsNadir Goksugur, Betul Ozbostanci, Sevil Bilir Goksugur
JournalPediatric dermatology (Pediatr Dermatol) 2007 Sep-Oct Vol. 24 Issue 5 Pg. E63-5 ISSN: 1525-1470 [Electronic] United States
PMID17958783 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • pimecrolimus
  • Tacrolimus
  • Administration, Topical
  • Adolescent
  • Humans
  • Immunosuppressive Agents (administration & dosage, adverse effects)
  • Male
  • Molluscum Contagiosum (etiology, pathology)
  • Molluscum contagiosum virus
  • Pityriasis (drug therapy)
  • Tacrolimus (administration & dosage, adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: